178 related articles for article (PubMed ID: 3134349)
41. Inhibition by heparin of thrombin-catalyzed activation of the factor VIII-von Willebrand factor complex.
Barrow RT; Healey JF; Lollar P
J Biol Chem; 1994 Jan; 269(1):593-8. PubMed ID: 8276857
[TBL] [Abstract][Full Text] [Related]
42. von Willebrand factor mediates protection of factor VIII from activated protein C-catalyzed inactivation.
Fay PJ; Coumans JV; Walker FJ
J Biol Chem; 1991 Feb; 266(4):2172-7. PubMed ID: 1846615
[TBL] [Abstract][Full Text] [Related]
43. Physiological Roles of the von Willebrand Factor-Factor VIII Interaction.
Kiouptsi K; Reinhardt C
Subcell Biochem; 2020; 94():437-464. PubMed ID: 32189311
[TBL] [Abstract][Full Text] [Related]
44. Factor VIII accelerates proteolytic cleavage of von Willebrand factor by ADAMTS13.
Cao W; Krishnaswamy S; Camire RM; Lenting PJ; Zheng XL
Proc Natl Acad Sci U S A; 2008 May; 105(21):7416-21. PubMed ID: 18492805
[TBL] [Abstract][Full Text] [Related]
45. Biological activity of von Willebrand factor during the manufacture of therapeutic factor VIII concentrates as determined by the collagen-binding assay.
Ramasamy I; Farrugia A; Tran E; Anastasius V; Charnock A
Biologicals; 1998 Jun; 26(2):155-66. PubMed ID: 9811523
[TBL] [Abstract][Full Text] [Related]
46. Investigation of a coagulation accelerating factor (CAF) in glomerulonephritis.
Salem HH; Howard MA; Koutts J; Firkin BG
Br J Haematol; 1985 Mar; 59(3):485-96. PubMed ID: 3918561
[TBL] [Abstract][Full Text] [Related]
47. Multimeric structure of platelet factor VIII/von Willebrand factor: the presence of larger multimers and their reassociation with thrombin-stimulated platelets.
Fernandez MF; Ginsberg MH; Ruggeri ZM; Batlle FJ; Zimmerman TS
Blood; 1982 Nov; 60(5):1132-8. PubMed ID: 6982084
[TBL] [Abstract][Full Text] [Related]
48. A novel mechanism of factor VIII protection by von Willebrand factor from activated protein C-catalyzed inactivation.
Nogami K; Shima M; Nishiya K; Hosokawa K; Saenko EL; Sakurai Y; Shibata M; Suzuki H; Tanaka I; Yoshioka A
Blood; 2002 Jun; 99(11):3993-8. PubMed ID: 12010799
[TBL] [Abstract][Full Text] [Related]
49. The pro-polypeptide of von Willebrand factor is required for the formation of a functional factor VIII-binding site on mature von Willebrand factor.
Leyte A; Voorberg J; Van Schijndel HB; Duim B; Pannekoek H; Van Mourik JA
Biochem J; 1991 Feb; 274 ( Pt 1)(Pt 1):257-61. PubMed ID: 1900418
[TBL] [Abstract][Full Text] [Related]
50. Use of surface plasmon resonance for studies of protein-protein and protein-phospholipid membrane interactions. Application to the binding of factor VIII to von Willebrand factor and to phosphatidylserine-containing membranes.
Saenko E; Sarafanov A; Greco N; Shima M; Loster K; Schwinn H; Josic D
J Chromatogr A; 1999 Aug; 852(1):59-71. PubMed ID: 10480230
[TBL] [Abstract][Full Text] [Related]
51. Factor VIII binding affects the mechanical unraveling of the A2 domain of von Willebrand factor.
Cao W; Cao W; Zhang W; Zheng XL; Zhang XF
J Thromb Haemost; 2020 Sep; 18(9):2169-2176. PubMed ID: 32544272
[TBL] [Abstract][Full Text] [Related]
52. A synthetic factor VIII peptide of eight amino acid residues (1677-1684) contains the binding region of an anti-factor VIII antibody which inhibits the binding of factor VIII to von Willebrand factor.
Foster PA; Fulcher CA; Houghten RA; Zimmerman TS
Thromb Haemost; 1990 Jun; 63(3):403-6. PubMed ID: 2119526
[TBL] [Abstract][Full Text] [Related]
53. Factor VIII and platelets synergistically accelerate cleavage of von Willebrand factor by ADAMTS13 under fluid shear stress.
Skipwith CG; Cao W; Zheng XL
J Biol Chem; 2010 Sep; 285(37):28596-603. PubMed ID: 20605782
[TBL] [Abstract][Full Text] [Related]
54. Factor VIII-East Hartford (arginine 1689 to cysteine) has procoagulant activity when separated from von Willebrand factor.
Aly AM; Hoyer LW
J Clin Invest; 1992 May; 89(5):1382-7. PubMed ID: 1569181
[TBL] [Abstract][Full Text] [Related]
55. Isolation of the factor VIII-von Willebrand factor complex directly from plasma by gel filtration.
Kaersgaard P; Barington KA
J Chromatogr B Biomed Sci Appl; 1998 Sep; 715(2):357-67. PubMed ID: 9792522
[TBL] [Abstract][Full Text] [Related]
56. Subunit structure of thrombin-activated porcine factor VIII.
Lollar P; Parker CG
Biochemistry; 1989 Jan; 28(2):666-74. PubMed ID: 2496750
[TBL] [Abstract][Full Text] [Related]
57. A new method measuring the interaction between von Willebrand factor and coagulation factor VIII.
Karlman M; Holmström M; Wiman B
Thromb Res; 2011 Jan; 127(1):47-50. PubMed ID: 21094987
[TBL] [Abstract][Full Text] [Related]
58. Isolation of small molecular forms of Factor VIII/von Willebrand factor from plasma.
Perret BA; Furlan M; Beck EA
Haemostasis; 1984; 14(4):289-95. PubMed ID: 6437941
[TBL] [Abstract][Full Text] [Related]
59. The effect of plasma von Willebrand factor on the binding of human factor VIII to thrombin-activated human platelets.
Nesheim M; Pittman DD; Giles AR; Fass DN; Wang JH; Slonosky D; Kaufman RJ
J Biol Chem; 1991 Sep; 266(27):17815-20. PubMed ID: 1917924
[TBL] [Abstract][Full Text] [Related]
60. A qualitative and quantitative analysis of von Willebrand factor contained in a very high-purity plasma-derived FVIII concentrate.
Samor B; Michalski C; Brandin MP; Andre MH; Chtourou S; Tellier Z
Vox Sang; 2012 Jul; 103(1):35-41. PubMed ID: 22239246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
